Synthesis and biological evaluation of PEGylated CuO nanoparticles

Journal of Inorganic Biochemistry

Volumn 164, Issue , 2016, Pages 82-90

  Giannousi, K ^a   Hatzivassiliou, E ^a   Mourdikoudis, S ^b   Vourlias, G ^a   Pantazaki, A ^a   Dendrinou Samara, C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

Anti inflammatory activity; Anticancer activity; Copper oxide nanoparticles

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; COPPER OXIDE NANOPARTICLE; DNA; LACTATE DEHYDROGENASE; LIPOXYGENASE; MACROGOL 1000; MACROGOL 8000; MACROGOL DERIVATIVE; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; COPPER; CUPRIC OXIDE; NANOPARTICLE; POLYETHYLENE GLYCOL 1000;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; COLLOID; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; ELECTROPHORESIS; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IC50; IN VITRO STUDY; MEMBRANE DAMAGE; MTT ASSAY; NANOFABRICATION; OXIDATIVE STRESS; PARTICLE SIZE; REACTION TIME; RELEASE ASSAY; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL MEMBRANE; CELL SURVIVAL; COPPER; DNA FRAGMENTATION; HEK293 CELLS; HELA CELLS; HUMANS; L-LACTATE DEHYDROGENASE; LIPOXYGENASE; NANOPARTICLES; POLYETHYLENE GLYCOLS;

EID: 84994012254     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2016.09.003     Document Type: Article

References (47)

1. [1] Marzano, C., Pellei, M., Tisato, F., Santini, C., Copper complexes as anticancer agents. Anti Cancer Agents Med. Chem. 9 (2009), 185–211.
2. [2] Sun, T., Zhang, Y.S., Pang, B., Hyun, D.C., Yang, M., Xia, Y., Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. 53 (2014), 12320–12364.
3. [3] Arora, S., Rajwade, J.M., Paknikar, K.M., Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 258 (2012), 151–165.
4. [4] AshaRani, P.V., Kah Mun, G.L., Hande, M.P., Valiyaveettil, S., Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3 (2009), 279–290.
5. [5] Wang, H., Zi, X.-Y., Su, J., et al. Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells. Int. J. Nanomedicine 7 (2012), 2641–2652.
6. [6] Xu, M., Fujita, D., Kajiwara, S., Minowa, T., Li, X., Takemura, T., Iwai, H., Hanagata, N., Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials 31 (2010), 8022–8031.
7. [7] Suresh, A.K., Pelletier, D.A., Doktycz, M.J., Relating nanomaterial properties and microbial toxicity. Nanoscale 5 (2013), 463–474.
8. [8] Giannousi, K., Avramidis, I., Dendrinou-Samara, C., Synthesis, characterization and evaluation of copper based nanoparticles as agrochemicals against Phytophthora infestans. RSC Adv. 3 (2013), 21743–21752.
9. [9] Giannousi, K., Lafazanis, K., Arvanitidis, J., Pantazaki, A., Dendrinou-Samara, C., Hydrothermal synthesis of copper based nanoparticles: antimicrobial screening and interaction with DNA. J. Inorg. Biochem. 133 (2014), 24–32.
10. 2O NPs: antifungal activity to yeast Saccharomyces cerevisiae and DNA interaction. Inorg. Chem. 53 (2014), 9657–9666.
11. [11] Azam, A., Ahmed, A.S., Oves, M., Khan, M.S., Memic, A., Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains. Int. J. Nanomedicine 7 (2012), 3527–3535.
12. [12] Chang, Y.-N., Zhang, M., Xia, L., Zhang, J., Xing, G., The toxic effects and mechanisms of CuO and ZnO nanoparticles. Materials 5 (2012), 2850–2871.
13. [13] Applerot, G., Lellouche, J., Lipovsk, A., Nitzan, Y., Lubart, R., Gedanken, A., Banin, E., Understanding the antibacterial mechanism of CuO nanoparticles: revealing the route of induced oxidative stress. Small 8 (2012), 3326–3337.
14. [14] Meghana, S., Kabra, P., Chakraborty, S., Padmavathy, N., Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv. 5 (2015), 12293–12299.
15. [15] Siddiqui, M.A., Alhadlaq, H.A., Ahmad, J., Al-Khedhairy, A.A., Musarrat, J., Ahamed, M., Copper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS One, 8, 2013, e69534.
16. [16] Laha, D., Pramanik, A., Maity, J., et al. Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7. Biochim. Biophys. Acta 2014 (1840), 1–9.
17. [17] Laurent, A., Nicco, C., Chereau, C., et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 65 (2005), 948–956.
18. [18] Karakoti, A.S., Das, S., Thevuthasan, S., Seal, S., PEGylated inorganic nanoparticles. Angew. Chem. Int. Ed. 50 (2011), 1980–1994.
19. [19] Jokerst, J.V., Lobovkina, T., Zare, R.N., Gambhir, S.S., Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6 (2011), 715–728.
20. [20] Ananth, A., Dharaneedharan, S., Heo, M.-S., Sun Mok, Y., Copper oxide nanomaterials: synthesis, characterization and structure-specific antibacterial performance. Chem. Eng. J. 262 (2015), 179–188.
21. [21] Wisastra, R., Dekker, F.J., Inflammation, cancer and oxidative lipoxygenase activity are intimately linked. Cancer 6 (2014), 1500–1521.
22. [22] Ulmer, D.D., Vallee, B.L., Wacker, W.E., Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. N. Engl. J. Med. 255 (1956), 450–456.
23. [23] Becerra, M.C., Eraso, A.J., Albesa, I., Comparison of oxidative stress induced by ciprofloxacin and pyoverdin in bacteria and in leukocytes to evaluate toxicity. Luminescence 18 (2003), 334–340.
24. [24] Harju, S., Fedosyuk, H., Peterson, K.R., Rapid isolation of yeast genomic DNA: Bust n’ Grab. BMC Biotechnol., 4, 2004, 10.1186/1472-6750-4-8.
25. [25] Herrmann, M., Lorenz, H.M., Voll, R., Grunke, M., Woith, W., Kalden, J.R., A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22 (1994), 5506–5507.
26. [26] Shahmiri, M., Ibrahim, N.A., Zainuddin, N., Asim, N., Bakhtyar, B., Zaharim, A., Sopian, K., Effect of pH on the synthesis of CuO nanosheets by quick precipitation method. WSEAS Transactions on Environment and Development 9 (2013), 137–146.
27. [27] Gilbert, B., Ono, R.K., Ching, K.A., Kim, C.S., The effects of nanoparticle aggregation processes on aggregate structure and metal uptake. J. Colloid Interface Sci. 339 (2009), 285–295.
28. [28] Sun, M., Zhu, A., Zhang, Q., Liu, Q., A facile strategy to synthesize mono disperse super paramagnetic OA-modified Fe3O4 nanoparticles with PEG assistant. J. Magn. Mater. 369 (2014), 49–54.
29. [29] Chen, K., Xue, D., pH-assisted crystallization of Cu2O: chemical reactions control the evolution from nanowires to polyhedra. CrystEngComm 14 (2012), 8068–8075.
30. [30] Huang, C.C., Hwu, J.R., Su, W.C., Shieh, D.B., Tzeng, Y., Yeh, C.S., Surfactant-assisted hollowing of Cu nanoparticles incorporating with halide-induced corrosion oxidation. Chem. Eur. J. 12 (2006), 3805–3810.
31. [31] Krishnan, S., Haseeb, A.S.M.A., Johan, M.R., Synthesis and growth kinetics of spindly CuO nanocrystals via pulsed wire explosion in liquid medium. J. Nanopart. Res. 15 (2013), 1410–1419.
32. [32] Park, Y., Whitaker, R.D., Nap, R.J., Paulsen, J.L., Mathiyazhagan, V., Doerrer, L.H., Song, Y.Q., Hürlimann, M.D., Szleifer, I., Wong, J.Y., Stability of superparamagnetic iron oxide nanoparticles at different pH values: experimental and theoretical analysis. Langmuir 28 (2012), 6246–6255.
33. [33] Zhang, Y.C., Tang, J.Y., Wang, G.L., Zhang, M., Hu, X.Y., Facile synthesis of submicron Cu2O and CuO crystallites from a solid metallorganic molecular precursor. J. Cryst. Growth 294 (2006), 278–282.
34. [34] Shen, L., Laibinis, P.E., Hatton, T.A., Bilayer surfactant stabilized magnetic fluids: synthesis and interactions at interfaces. Langmuir 15 (1999), 447–453.
35. [35] Bastami, T.R., Entezari, M.H., Hua, Q.H., Hartono, S.B., Qia, S.Z., Role of polymeric surfactants on the growth of manganese ferrite nanoparticles. Chem. Eng. J. 210 (2012), 157–165.
36. [36] Mu, Q., Jiang, G., Chen, L., et al. Chemical basis of interactions between engineered nanoparticles and biological systems. Chem. Rev. 114:15 (2014), 7740–7781.
37. [37] Unfried, K., Albrecht, C., Klotz, L.-O., von Mikecz, A., Grether-Beck, S., Schins, R.P.F., Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1 (2007), 52–71.
38. [38] Sohaebuddin, S.K., Thevenot, P.T., Baker, D., Eaton, J.W., Tang, L., Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol., 7, 2010, 22.
39. [39] Szatrowski, T.P., Nathan, C.F., Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991), 794–798.
40. [40] Kroemer, G., Petit, P., Zamzami, N., Vayssiere, J.L., Mignotte, B., The biochemistry of programmed cell death. FASEB J. 9 (1995), 1277–1287.
41. [41] Lee, I.-C., Ko, J.-W., et al. Comparative toxicity and biodistribution of copper nanoparticles and cupric ions in rats. Int. J. Nanomedicine 11 (2016), 2883–2900.
42. [42] Chen, M., Mikecz, A., Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp. Cell Res. 305:1 (2005), 51–62.
43. [43] Alomar, S., Cadmium sulfide nanoparticle induces oxidative stress and pro-inflammatory effects in human lung adenocarcinoma epithelial cells. Toxicol. Environ. Chem. 97 (2015), 5,619–5,633.
44. [44] Nowsheen, K., Aziz, T.B., Kryston, N.F., Ferguson, N.F., Georgakilas, A., The interplay between inflammation and oxidative stress in carcinogenesis. Curr. Mol. Med. 12 (2012), 672–680.
45. [45] Guo, C., Nie, D., Are lipoxygenases valid targets of cancer prevention and treatment?. J. Carcinogen. Mutagen., 2012, S1, 10.4172/2157-2518.S1-008.
46. [46] Tong, W.G., Ding, X.Z., Adrian, T.E., The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 296 (2002), 942–948.
47. 4 NPs for the sustained release of anti-inflammatory drug naproxen and in vivo target selectivity. ACS Appl. Mater. Interfaces 8:14 (2016), 9345–9360.